Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

GLUEGLUE
Showing 8 of 20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in MONTE ROSA THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.9M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $45.1M as of 2026-Q2. The position was increased (+21.0% shares). GLUE represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$45.1M

Current Shares

1.9M

Total Value Change

+$39.6M

Total Shares Change

+819,424

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+21.0%
$45.1M0.0%$24.20
35
2026-Q1
Increased
1.5M
+27.9%
$25.4M0.0%$17.96
36
2025-Q4
Increased
1.2M
+4.6%
$18.9M0.0%$15.97
30
2025-Q3
Increased
1.2M
+2.4%
$8.5M0.0%$7.31
28
2025-Q2
Increased
1.1M
+12.0%
$5.1M0.0%$4.60
30
2025-Q1
Decreased
1M
-3.1%
$4.7M0.0%$5.10
0
2024-Q4
Decreased
1M
-0.8%
$7.2M0.0%$7.02
0
2024-Q3
Increased
1M
+23.3%
$5.5M0.0%$5.17
33

Other major holders of GLUE: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used